FCGR2B and acquired epidermolysis bullosa: These data confirm the importance of FcγRIIB as an important negative regulator of IgG aAb-driven ROS release from neutrophils in active experimental EBA, most likely induced through IgG1 aAbs that trigger FcγRIII.